Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older
- People with chronic left-sided heart failure who are still experiencing symptoms despite being on stable, guideline-recommended heart failure medications for at least 1 month
- People who have been hospitalised for heart failure in the past 12 months, and whose blood test results show elevated heart failure markers (BNP or NT-proBNP) within the past 6 months — the specific levels required depend on whether the person has a normal heart rhythm or atrial fibrillation (confirm with trial site)
- People whose heart pressure measurements, taken during a cardiac catheterisation procedure, show a resting lung capillary wedge pressure or left atrial pressure of 15 mmHg or higher, with a specific pressure difference between the lung and right heart chambers also met (confirm with trial site)
- People with a heart function classification of Grade II, III, or IV on the standard NYHA scale — meaning symptoms ranging from mild to severe
- People (or their legal guardian) who are able to understand the purpose of the study, agree to take part voluntarily, and sign a written consent form, and who are able to attend follow-up appointments
Who may not be able to join:
- People with a major heart valve disease or severe blocked heart arteries that currently require surgical treatment, or a heart condition that currently requires a pacemaker
- People with pulmonary hypertension where the resistance in the lung blood vessels exceeds 4 Wood Units
- People who have had a heart attack or heart surgery within the past three months
- People with an active heart infection (infective endocarditis), or where imaging has found blood clots or abnormal growths inside the heart
- People whose heart or blood vessel anatomy makes the procedure technically impossible or medically unsuitable
- People whose life expectancy is estimated to be less than 12 months
- People who have had a stroke, a mini-stroke (transient ischaemic attack), a blood clot in a deep vein, or a blood clot in the lungs within the past 6 months
- Women who are pregnant or breastfeeding, or people who are planning to have a child within the next year
- People who are considered unlikely to follow the study requirements or complete the full study as needed
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: yan wang, dean, Xiamen Cardiovascular Hospital, Xiamen University
Phone: +8613774401524
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The clinical treatment success rate was 12 months after operation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.